Erratum: Retracted: Neuropilin-1highCD4+CD25+Regulatory T Cells Exhibit Primary Negative Immunoregulation in Sepsis (Mediators of Inflammation (2016) 2016 (7132158) DOI: 10.1155/2016/7132158);Neuropilin-1highCD4+CD25+ Regulatory T Cells Exhibit Primary Negative Immunoregulation in Sepsis

Mediators of Inflammation

Volumn 2016, Issue , 2016, Pages

  Gao, Yu Lei ^a   Chai, Yan Fen ^a   Qi, An Long ^a   Yao, Ying ^a   Liu, Yan Cun ^a   Dong, Ning ^b   Wang, Li Jun ^a   Yao, Yong Ming ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 10; NEUROPILIN 1; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; FORKHEAD TRANSCRIPTION FACTOR; FOXP1 PROTEIN, MOUSE; IL10 PROTEIN, HUMAN; INTERLEUKIN 2 RECEPTOR ALPHA; NEUROPILIN; REPRESSOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; COCULTURE; CONTROLLED STUDY; DEMETHYLATION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOREGULATION; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; REGULATORY T LYMPHOCYTE; SEPSIS; SURVIVAL RATE; ANIMAL; BAGG ALBINO MOUSE; CD4+ T LYMPHOCYTE; DISEASE MODEL; IMMUNOLOGY; METABOLISM;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CTLA-4 ANTIGEN; DISEASE MODELS, ANIMAL; FORKHEAD TRANSCRIPTION FACTORS; INTERLEUKIN-10; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; MICE; MICE, INBRED BALB C; NEUROPILINS; REPRESSOR PROTEINS; SEPSIS; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 84971611934     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2020/9195623     Document Type: Erratum

References (31)

1. W. Gu, F. Wang, J. Bakker, L. Tang, and J. Liu, "The effect of goaldirected therapy on mortality in patients with sepsis-earlier is better: A meta-analysis of randomized controlled trials," Critical Care, vol. 18, article 570, 2014.
2. K.-M. Kaukonen, M. Bailey, D. Pilcher, D. J. Cooper, and R. Bellomo, "Systemic inflammatory response syndrome criteria in defining severe sepsis,"The New England Journal ofMedicine, vol. 372, no. 17, pp. 1629-1638, 2015.
3. D. F. Gaieski, J. M. Edwards, M. J. Kallan, and B. G. Carr, "Benchmarking the incidence and mortality of severe sepsis in theUnited States," Critical CareMedicine, vol. 41,no. 5, pp. 1167-1174, 2013.
4. B. D. Winters, M. Eberlein, J. Leung, D. M. Needham, P. J. Pronovost, and J. E. Sevransky, "Long-term mortality and quality of life in sepsis: A systematic review," Critical Care Medicine, vol. 38, no. 5, pp. 1276-1283, 2010.
5. L. U. Taniguchi, A. L. Bierrenbach, C. M. Toscano, G. P. P. Schettino, and L. C. P. Azevedo, "Sepsis-related deaths in Brazil: An analysis of the nationalmortality registry from 2002 to 2010," Critical Care, vol. 18, no. 6, article R608, 2014.
6. L. P. Skrupky, P. W. Kerby, and R. S. Hotchkiss, "Advances in the management of sepsis and the understanding of key immunologic defects," Anesthesiology, vol. 115, no. 6, pp. 1349-1362, 2011.
7. J. S. Boomer, K. To, K. C. Chang et al., "Immunosuppression in patients who die of sepsis and multiple organ failure," JAMA, vol. 306, no. 23, pp. 2594-2605, 2011.
8. C. J. Darcy, G. Minigo, K. A. Piera et al., "Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients," Critical Care, vol. 18, no. 4, article R163, 2014.
9. S. Inoue, K. Suzuki-Utsunomiya, Y. Okada et al., "Reduction of immunocompetent T cells followed by prolonged lymphopenia in severe sepsis in the elderly," Critical Care Medicine, vol. 41, no. 3, pp. 810-819, 2013.
10. K. Chang, C. Svabek, C. Vazquez-Guillamet et al., "Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis," Critical Care, vol. 18, no. 1, article R3, 2014.
11. M. M. Stevenson, R. Ing, F. Berretta, and J. Miu, "Regulating the adaptive immune response to blood-stage malaria: role of dendritic cells and CD4+Foxp3+ regulatory T cells," International Journal of Biological Sciences, vol. 7, no. 9, pp. 1311-1322, 2011.
12. D. C. Nascimento, J. C. Alves-Filho, F. Sonego et al., "Role of regulatory T cells in long-term immune dysfunction associated with severe sepsis," Critical Care Medicine, vol. 38, no. 8, pp. 1718-1725, 2010.
13. R. Tatura, M. Zeschnigk,W. Hansen et al., "Relevance of Foxp3+ regulatory T cells for early and late phases of murine sepsis," Immunology, vol. 146, no. 1, pp. 144-156, 2015.
14. Q.-Y. Liu, Y.-M. Yao, Y. Yu, N. Dong, and Z.-Y. Sheng, "Astragalus polysaccharides attenuate postburn sepsis via inhibiting negative immunoregulation of CD4+CD25high T cells," PLoS ONE, vol. 6, no. 6,Article ID e19811, 2011.
15. X.-M. Zhu, Y.-M. Yao, H.-P. Liang et al., "High mobility group box-1 protein regulate immunosuppression of regulatory T cells through toll-like receptor 4," Cytokine, vol. 54, no. 3, pp. 296-304, 2011.
16. Y. Zhang, Y.-M. Yao, L.-F. Huang, N. Dong, Y. Yu, and Z.-Y. Sheng, "The potential effect and mechanism of high-mobility group box 1 protein on regulatory T cell-mediated immunosuppression," Journal of Interferon and Cytokine Research, vol. 31, no. 2, pp. 249-257, 2011.
17. Y. Y. Luan, C. F. Yin, Q. H. Qin et al., "Effect of regulatory T cells on promoting apoptosis of T lymphocyte and its regulatory mechanismin sepsis," Journal of Interferon&Cytokine Research, vol. 35, no. 12, pp. 969-980, 2015.
18. R. Roskoski Jr., "Vascular endothelial growth factor (VEGF) signaling in tumor progression," Critical Reviews in Oncology/ Hematology, vol. 62, no. 3, pp. 179-213, 2007.
19. H. Fujisawa, T. Kitsukawa, A. Kawakami, S. Takagi,M. Shimizu, and T. Hirata, "Roles of a neuronal cell-surface molecule, neuropilin, in nerve fiber fasciculation and guidance," Cell and Tissue Research, vol. 290, no. 2, pp. 465-470, 1997.
20. K. Singh, M. Hjort, L. Thorvaldson, and S. Sandler, "Concomitant analysis of Helios and Neuropilin-1 as a marker to detect thymic derived regulatory T cells in nä?ve mice," Scientific Reports, vol. 5, article 7767, 2015.
21. M. Campos-Mora, R. A. Morales, F. Pérez et al., "Neuropilin-1+ regulatory T cells promote skin allograft survival and modulate effector CD4+ T cells phenotypic signature," Immunology and Cell Biology, vol. 93, no. 2, pp. 113-119, 2015.
22. G. M. Delgoffe, S.-R. Woo, M. E. Turnis et al., "Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis," Nature, vol. 501, no. 7466, pp. 252-256, 2013.
23. M. Yadav, C. Louvet, D. Davini et al., "Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo," The Journal of Experimental Medicine, vol. 209, no. 10, pp. 1713-1722, 2012.
24. D. Bruder, M. Probst-Kepper, A. M. Westendorf et al., "Frontline: neuropilin-1: A surface marker of regulatory T cells," European Journal of Immunology, vol. 34, no. 3, pp. 623-630, 2004.
25. B. D. Solomon, C. Mueller,W. Chae, L. M. Alabanza, and M. S. Bynoe, "Neuropilin-1 attenuates autoreactivity in experimental autoimmune encephalomyelitis," Proceedings of the National Academy of Sciences, vol. 108, no. 5, pp. 2040-2045, 2011.
26. Y. L. Gao, Y. F. Chai, N. Dong et al., "Tuftsin-derived T-peptide prevents cellular immunosuppression and improves survival rate in septic mice," Scientific Reports, vol. 5, Article ID 16725, 2015.
27. A. Battaglia, A. Buzzonetti, G. Monego et al., "Neuropilin-1 expression identifies a subset of regulatory T cells in human lymph nodes that is modulated by preoperative chemoradiation therapy in cervical cancer," Immunology, vol. 123, no. 1, pp. 129-138, 2008.
28. R. S. Hotchkiss and I. E. Karl, "The pathophysiology and treatment of sepsis," New England Journal of Medicine, vol. 348, no. 2, pp. 138-150, 2003.
29. R. S. Hotchkiss, G. Monneret, and D. Payen, "Sepsisinduced immunosuppression: from cellular dysfunctions to immunotherapy," Nature Reviews Immunology, vol. 13, no. 12, pp. 862-874, 2013.
30. K. C. Chang, C.-A. Burnham, S. M. Compton et al., "Blockade ofthe negative co-stimulatory molecules PD-1 and CTLA-4 improves survival in primary and secondary fungal sepsis," Critical Care, vol. 17, no. 3, article R85, 2013.
31. O. M. Peck-Palmer, J. Unsinger, K. C. Chang, C. G. Davis, J. E. McDunn, and R. S. Hotchkiss, "Deletion of MyD88 markedly attenuates sepsis-induced T and B lymphocyte apoptosis but worsens survival," Journal of Leukocyte Biology, vol. 83, no. 4, pp. 1009-1018, 2008.